HEART FAILURE WITH PRESERVED EJECTION FRACTION
Clinical trials for HEART FAILURE WITH PRESERVED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH PRESERVED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH PRESERVED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart failure drug study halted early after only 4 patients
Disease control TerminatedThis early-stage study tested a new drug called HS135 in obese people with both heart failure (with preserved pumping ability) and high blood pressure in the lungs. The trial was stopped early after enrolling only 4 participants, so no conclusions can be drawn about safety or eff…
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase: PHASE1 • Sponsor: 35Pharma Inc • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
New heart failure drug shows promise in Mid-Stage trial
Disease control TerminatedThis study tested a new drug called LY3540378 in 332 adults with worsening chronic heart failure where the heart pumps normally but doesn't fill properly. The goal was to see if the drug could improve heart function and safety compared to a placebo. The trial was terminated early…
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Heart failure exercise program shows promise, study ends early
Symptom relief TerminatedThis study tested a video-based coaching program to help adults with heart failure exercise regularly. Eleven people took part, and the program offered online exercise classes and access to hospital gyms. The goal was to see if participants could exercise at least 120 minutes per…
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase: NA • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Heart drug study explores sex differences, but ends early
Knowledge-focused TerminatedThis study aimed to see if a drug called PL-3994 affects heart function differently in men and women with a type of heart failure (HFpEF). Researchers planned to measure heart chemicals and blood pressure in 15 people. However, the study was stopped early, so results are limited.
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase: PHASE2 • Sponsor: Palatin Technologies, Inc • Aim: Knowledge-focused
Last updated May 26, 2026 05:06 UTC